Savient Pharmaceuticals, Inc.

Savient Pharmaceuticals, Inc. - East Brunswick, NJ; changed name from Bio-Technology General Corp. in June 2003; divested its biophamaceutical lines of business to Ferring BV in mid-2005 for $80 million; acquired by Crealta in late 2013

Related product monographs:

1. Somatropin, rDNA/Genentech -- Patent dispute
2. Somatropin, rDNA/Novo Nordisk -- Tech. ; Patent dispute
3. Somatropin, rDNA/Ferring -- R&D ; Former
4. Urate oxidase, rDNA, PEG- -- R&D ; Tech. ; World mark.

Location - East Brunswick NJ USA

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute